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Objective: To assess 3D morphological variations and local and systemic biomarker proﬁles in subjects
with a diagnosis of temporomandibular joint osteoarthritis (TMJ OA).
Design: Twenty-eight patients with long-term TMJ OA (39.9 ± 16 years), 12 patients at initial diagnosis of
OA (47.4 ± 16.1 years), and 12 healthy controls (41.8 ± 12.2 years) were recruited. All patients were female
and had cone beam CT scans taken. TMJ arthrocentesis and venipuncture were performed on 12 OA and
12 age-matched healthy controls. Serum and synovial ﬂuid levels of 50 biomarkers of arthritic inﬂam-
mation were quantiﬁed by protein microarrays. Shape Analysis MANCOVA tested statistical correlations
between biomarker levels and variations in condylar morphology.
Results: Compared with healthy controls, the OA average condyle was signiﬁcantly smaller in all di-
mensions except its anterior surface, with areas indicative of bone resorption along the articular surface,
particularly in the lateral pole. Synovial ﬂuid levels of ANG, GDF15, TIMP-1, CXCL16, MMP-3 and MMP-7
were signiﬁcantly correlated with bone apposition of the condylar anterior surface. Serum levels of ENA-
78, MMP-3, PAI-1, VE-Cadherin, VEGF, GM-CSF, TGFbb1, IFNgg, TNFaa, IL-1aa, and IL-6 were signiﬁcantly
correlated with ﬂattening of the lateral pole. Expression levels of ANG were signiﬁcantly correlated with
the articular morphology in healthy controls.
Conclusions: Bone resorption at the articular surface, particularly at the lateral pole was statistically
signiﬁcant at initial diagnosis of TMJ OA. Synovial ﬂuid levels of ANG, GDF15, TIMP-1, CXCL16, MMP-3
and MMP-7 were correlated with bone apposition. Serum levels of ENA-78, MMP-3, PAI-1, VE-Cad-
herin, VEGF, GM-CSF, TGFb1, IFNg, TNFa, IL-1a, and IL-6 were correlated with bone resorption.
Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International.Introduction
The great challenge in Osteoarthritis (OA) treatment is that often
the disease cannot be diagnosed until it becomes symptomatic, atL.H.S. Cevidanes, Department
rsity of Michigan School of
8109-1078, USA.
gmail.com (L.H.S. Cevidanes).
eoarthritis Research Society Internwhich point structural alterations already are advanced. The
ascertainment of variations between health and disease is essential
information for detecting inﬂammatory and degenerative condi-
tions of the tissues affected1,2. An important emerging theme in OA
is a broadening of focus from a disease of cartilage to a disease of
the entire joint and the multiple biological systems that interact
with one another in this disease. A variety of etiologic risk factors
such as age, sex, trauma, overuse, genetics, hormones, and obesity
contribute to the disease progressive nature in differentational.
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components of the joint, which takes place over years, results in
degradation of the articular cartilage and disc, bony changes, sy-
novial proliferation, muscle and tendon weakness, and fatigue.3
The temporomandibular joint (TMJ) condyle is the site of
numerous dynamic morphologic transformations in the initiation/
progression of OA, which are not merely manifestations secondary
to cartilage degradation. The TMJ differs from other joints because a
layer of ﬁbrocartilage, and not hyaline cartilage, covers it. The bone
of the mandibular condyles is located just beneath the ﬁbro-
cartilage, making it particularly vulnerable to inﬂammatory dam-
age and a valuablemodel for studying arthritic bony changes.While
extensive assessments of arthritis in other joints have focused on
loss or damage of hyaline cartilage, the capacity of cartilage to
repair/modify the surrounding extracellular matrix is limited in
comparison to bone4 (Fig. 1). Thus, a strong rationale exists for
therapeutic approaches that target bone resorption and formation
and take into account the complex cross-talk between all of the
joint tissues.
No proven disease-modifying therapy exists for arthritis and
current treatment options for chronic arthritic pain are insufﬁ-
cient5. The NIH-funded OA Biomarkers Network established a
system for categorizing biomarkers known as the BIPED system,
where BIPED stands for burden of disease, investigative, prognostic,
efﬁcacy of intervention, and diagnostic6. Over 100 protein media-
tors associated with arthritis initiation and progression, such as
nociception, inﬂammation, angiogenesis and bone resorption, haveFig. 1. A e The TMJ is a unique joint where the bone of the mandibular condyles is located ju
to inﬂammatory damage and a valuable model for studying arthritic bony changes. The TM
agnosed patient who presented Idiopathic Condylar Resorption who was treated orthodonti
by shape analysis.been identiﬁed7e13. The recent work of Slade et al. suggests that not
only local proteins in the synovial ﬂuid may play a role in the cross-
talk among the different joint tissues, but also circulating levels of
pro-inﬂammatory proteins and systemic processes may contribute
to the pathophysiology of disorders of the TMJ.14
With many affected tissues in TMJ OA, it is unlikely a single
biomarker would drive and provide a comprehensive description
of this intricate disease7,10,13,15. Individual proteins are produced
by and act on many cell types, and in many cases proteins have
similar actions. It was the goal of this study to work towards a
paradigm shift from looking for one speciﬁc biomarker to identify
a disease process to the concept of looking for sets of biological
and bone imaging markers to categorize a complex disease16.
Speciﬁcally, this study proposed to: (1) identify 3D morphological
variations in asymptomatic controls, subjects at initial diagnosis
TMJ OA and subjects with long term history of TMJ OA; and (2)
assess systemic (serum) and local (synovial ﬂuid) biomarker
proﬁles in early onset of TMJ OA subjects, as compared to age
matched controls. We hypothesized that bone morphology is
characteristically different in OA compared to controls even at
early diagnosis, and that variations in protein levels would
correlate to the patterns of bone destruction and repair in the
articular surfaces of the condyles in TMJ OA. To test these hy-
potheses, we determined associations of (1) circulating proteins
with condylar morphology and case status of OA and healthy
controls; and (2) synovial ﬂuid proteins with condylar
morphology and case status of OA and healthy controls.st beneath the ﬁbrocartilage, and not hyaline cartilage, making it particularly vulnerable
J condyle is the site of numerous dynamic morphological transformations. B e Undi-
cally between 2001 and 2004. C e Note the progressive condylar resorption quantiﬁed
Fig. 2. A and B e Landmark-based registration used to approximate condyles from all subjects in the group comparisons. A. 25 points in the ramus and condyle surfaces used for the
landmark-based registration, B. Reference condylar model (red) with the overlay of multiple condyles approximated in the same coordinate system, C e Parameterization of 4,002
homologous or correspondent surface mesh points for statistical comparisons and detailed phenotypic characterization, D e Examples 3D surface models constructed from CBCT
images for a subset of 15 patients in this study.
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Twenty-eight patients with long-term TMJ OA (39.9 ± 16
years), 12 patients at initial consult diagnosis of OA (47.4 ± 16.1
years) and 12 healthy controls (41.8 ± 12.2 years), recruited from
the university clinic and through advertisement, underwent a
clinical exam by an orofacial pain specialist using the RDC
guidelines. All patients were female. Following clinical diagnosis
of TMJ OA or health, a 20-s Cone beam CT (CBCT) scan was taken
on all participants, using a large ﬁeld of view to include both
TMJs. The datasets obtained consisted of approximately 300
axial cross-sectional slices with voxels reformatted to an
isotropic 0.5  0.5  0.5 mm. Twelve OA and 12 age-matched
controls also had TMJ arthrocentesis and venipuncture. This
study is in concordance with STrengthening the Reporting of
OBservational studies in Epidemiology (STROBE) guidelines for
observational studies The data acquisition and analysis in this
study was approved by the University Institutional Review
Board.Image analysis methods
The process of construction of surface models from the CBCTs to
perform the regional superimposition is called segmentation
(performed with open-source ITK-SNAP 2.4 software, www.
itksnap.org)17. 3D surface mesh models of the right and left
mandibular condyles were constructed by outlining the cortical
boundaries of the condylar region using semi-automatic discrimi-
nation procedures, that allowed manual editing, checking slice by
slice in all three planes of space. After generating all 3D surface
models, left condyles were mirrored in the sagittal plane to form
right condyles to facilitate comparisons. All condylar models were
then cropped to a more deﬁned region of interest consisting of only
the condyle and a portion of the ramus. Twenty-ﬁve surface points
were selected on each condyle by one observer at corresponding
(homologous) areas to closely approximate the various anatomic
regions of all individuals who present marked morphological
variability: four points evenly spaced along the superior surface of
the sigmoid notch, four on the medial and lateral portions of the
L.H.S. Cevidanes et al. / Osteoarthritis and Cartilage 22 (2014) 1657e16671660ramus adjacent to the sigmoid notch, three along the posterior neck
of the condyle, three on the medial and three on the lateral portion
of the condylar neck, and on the medial, lateral, anterior, and
posterior extremes of the condylar head [Fig. 2(A)].18
After registration, the cropping areas across 3D models were
normalized and binary volumes were created from the surface
models. SPHARM-PDM software 1.12 (open-source, http://www.
nitrc.org/projects/spharm-pdm)19e22 was used to generate a
mesh approximation from the volumes, whose points were map-
ped to a “spherical map”. In that spherical map, parameterization
determined coordinate poles on each condylar model that allow
the models to be related to one another in a consistent manner and
identiﬁed 4,002 correspondent surface mesh points for statistical
comparisons and detailed phenotypic characterization [Fig. 2(B)].
An average 3D condylar shapewas generated for the TMJ OA groups
and control group. Additionally, another set of average OA and
control models were generated using only the condyle sampled by
arthrocentesis for each participant, which were utilized in the
second part of the study. The CBCT datasets were also indepen-
dently interpreted by two Oral and maxillofacial radiologists. These
interpretations were not used to classify participants as subjects or
controls, but were later compared to the clinical ﬁndings.
Collection of biological samples
TMJ arthrocentesis was performed by an experienced OMF
surgeon using a validated protocol23e29. Synovial ﬂuid was
collected for only one TMJ for each patient. The joint chosen for
arthrocentesis was selected based on the opinion of the pain
specialist as to which joint was most affected. If both joints were
equally affected, or if neither joint appeared to be affected (as with
the control patients), the right joint was chosen. Arthrocentesis was
performed using a push/pull technique in which 4 ml of a saline
solution was injected into the joint and then 4 ml of solution
withdrawn under local anesthesia. The saline solution consisted of
78% saline and 22% hydroxocobalamin, which is included in order
to determine the volume of synovial ﬂuid recovered in the aspirate
by comparing the spectrophotometric absorbance of the aspirate
with that of the washing solution. Venipuncture was performed on
the median cubital vein of each patients' left arm and 5 ml of blood
was obtained. Intravenous sedation for the aforementioned pro-
cedures was offered to each participant.
Measurements of biological samples
Custom quantibody protein microarrays RayBiotech (Norcross,
GA) were used to evaluate the synovial ﬂuid and serum samples for
50 biomarkers. This assay is array-based multiplex sandwich ELISA
system for simultaneous, quantitative measurement the concen-
tration of multiple proteins. Like an ELISA, it uses a pair of antigen-
speciﬁc antibodies to capture the protein of interest. The use of
biotinylated antibodies and a streptavidin-conjugated ﬂuor allow
detection levels for the speciﬁc proteins to be visualized using a
ﬂuorescence laser scanner30. For protein quantiﬁcation, the reagent
kit included protein standards, whose concentration had been
predetermined, provided to generate a six-point standard curve of
each protein. Standards and samples were assayed simultaneously.
By comparing signals from unknown samples to the standard
curve, the unknown protein concentrations in the samples were
determined. Positive controls for each biomarker were included in
each array and the array data obtained from densitometry were
inputted into the appropriate cells of the corresponding analysis
tool, which plotted the standard curve for each analyte in addition
to performing background subtraction/normalization. The bio-
markers chosen were known to be associated with bone repair anddegradation, inﬂammation or nociception, common processes seen
in OA. Preprocessing steps for these samples were completed at the
School of Dentistry and then shipped to RayBiotech for analysis. All
samples were evaluated in duplicate using two separate slides with
19 and 31 proteins respectively, to control for proteins with cross-
reactivity (the array with 19 proteins included aFGF, MMP-3,
ANG, MMP-7, BDNF, MMP-9. BMP-2, NT-3, CXCL14/BRAK, PAI-1,
GDNF, RANK, ICAM-1, TIMP-1, ICAM-3,VE-Cadherin, MIP-1b,
MMP-10 and MMP-2; the array with 31 proteins included 6ckine,
IFNg, NT-4, bFGF, IGF-1,OPG, BLC, IL-1a, TGFb1, CXCL16, IL-1b,
TGFb2, EGF,IL-6, TGFb3, ENA-78, LIF, TIMP-2, FGF-7,MCP-1, TNFa, G-
CSF, MIP-1a, TNFb, GDF-15, MMP-1,VEGF, GM-CSF, MMP-13, HB-
EGF and NGF R).
Statistical analysis
The statistical framework for testingmorphological variations of
the condyles of 104 condyles included a Hotelling T-squared test in
a multivariate analysis of covariance (Shape analysis MAN-
COVA)31,32 corrected for false discovery rate at 0.05; and for testing
high dimensional hypothesis, DirectioneProjectionePermutation
(DiProPerm)33, aimed at rigorously testing whether lower dimen-
sional graphically visual differences are statistically signiﬁcant.
DiProPerm was assessed by three steps of determining Direction
(project samples onto an appropriate direction), Projection
(calculate univariate two sample statistic) and Permutation (assess
signiﬁcance using permutation test). Distance Weighted Discrimi-
nation (DWD) calculated a direction vector to classify high
dimensional datasets. Because the control and OA samples have
different sample size, an appropriately weighted versions of DWD,
wDWD33, was used to ﬁnd a direction vector in the feature space
separating the morphology groups. The group membership was
permuted 1000 times in this study.
Shape analysis MANCOVA was also used to test point-wise as-
sociations between each protein levels and individual differences in
each one of the correspondent 4002 surface points in the
morphology of each of the control and OA condyles with a signif-
icance level of 0.05. Because the condylar surface mesh data is
recorded in three dimensions (x, y, and z) at 4002 locations and the
sample size is only 12 condyles in each group, which represent high
dimensional low sample size data, these ﬁndings were corrected
for multiple comparisons by using a false discovery rate of 0.2.
Results
In the Radiologists' interpretation of the CBCTs, for the asymp-
tomatic control group, 41.7% of condyles were classiﬁed as having
OA, 45.8% as indeterminate and 12.5% as normal. In the OA groups,
all patients presented at least one of the condyles, right or left side
with radiographic diagnosis of OA. In some patients one of the
condyles was less affected, indeterminate or non-affected. In the
initial diagnosis of OA group, 70.8% of condyles were given a
radiographic diagnosis of OA while 25% were indeterminate based
on the RDC criteria. In the long-term history of OA group, 80.4% of
the condyles were given a radiographic diagnosis of OA (Table I).
These results are in comparison to the clinical diagnosis, which by
design consisted of 50% OA and 50% normal. Qualitative assessment
of the semi-transparent overlays revealed that even at their initial
diagnostic appointment OA patient already present marked bone
changes that are more marked in the group with long history of OA
(Fig. 3). The DiProPerm test found a statistically signiﬁcant
morphological difference (P-value ¼ 0.0016) in the healthy control
and the OA group with 1000 permutation statistics (Fig. 3). Quan-
titative assessment of group comparisons were reported using
vector distancemaps and signed distance maps computed locally at
Table I
Description of the sample clinical and radiographic diagnoses
Clinical diagnosis (n ¼ 51 patients, 102 condyles) Radiographic diagnosis (n ¼ 102 condyles)
Mean age OA Indeterminate Healthy
Healthy asymptomatic control (n ¼ 11 patients, 22 condyles) 41.8 ± 12.2 45.5% (n ¼ 10) 40.9% (n ¼ 9) 13.6% (n ¼ 3)
Initial diagnosis of OA (n ¼ 12 patients, 224 condyles) 44.4 ± 14.4 70.8% (n ¼ 17) 25% (n ¼ 6) 4.2% (n ¼ 1)
Chronic OA (n ¼ 28 patients, 56 condyles) 39.9 ± 16 80.4% (n ¼ 45) 17.8% (n ¼ 10) 13.6% (n ¼ 3)
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smaller size in all dimensions and areas of statistically signiﬁcant
difference were in the superior articular surface of the condyles
particularly in the anterior and superior portion of the lateral pole
(2.3 mm indicative of bone resorption at the initial diagnosis
group and 3.4 mm in the long-term group. In the anterior surface
of the condyle, a small area of 1.7 mm of bone appositionwas noted
at initial diagnosis and 2.7mm at the long-termOA averagemodels.
When the initial diagnosis and long term OA average models were
compared, statistically signiﬁcant differences indicative of pro-
gression of bone resorption were noted along the whole condylar
surface except at the superior surface of the lateral pole (Fig. 4).
The results of the standard curves for both serum and synovial
ﬂuid showed that each essay detected awide range of protein levels
(both above and below the limits for certain biomarkers). Of the 50
biomarkers, the levels of 32 were consistently measured within the
standard curve of detection in either blood and/or synovial ﬂuid as
presented in Table II. Proteins levels below the limit of detection in
either blood and/or synovial ﬂuid are shown with red borders. Ten
synovial ﬂuid biomarkers and one serum biomarker highlighted in
Table II demonstrated close to two-fold or greater variation be-
tween the OA and control groups. Because of the high variability inFig. 3. Semi-transparent overlays of group average morphologies and DiProPerm statistics
appointment OA patients already present marked bone changes that are more severe in the g
distribution of the data projected onto the DWD direction, illustrating how well the two gr
reﬂects order in the data set, to avoid overplotting. The curves are smooth histograms, black
panel shows the results of the DiProPerm hypothesis test. 1000 permuted realizations of the
black dots, and the ﬁt of a Gaussian distribution to the black dots is the thin curve. Comparing
show a strongly signiﬁcant result.detection levels and small sample size of 12 matched pairs, median
values rather than mean values for the biomarker detection levels
are presented.
Of the 32 proteins detected above threshold, associations with
the variability in condylar morphology at speciﬁc anatomic regions
(P < 0.05) shown by Pearson Correlation color maps using the
MANCOVA analysis were observed for 22 proteins: 10 in the sy-
novial ﬂuid, 8 of these same proteins in serum, and other 12 pro-
teins in serum samples (Fig. 5).
In the synovial ﬂuid of patients with clinical diagnosis of OA,
6ckine and ENA-78 levels showed small areas of correlations
with morphological differences in the lateral pole morphology.
ANG, GDF15, TIMP-1, CXCL16, MMP-7 and MMP-3 showed small
areas of correlations with morphological differences in the
anterior surface of the condyle. MMP-3 levels were more than
two fold lower in OA compared to controls in synovial ﬂuid and
presented signiﬁcant correlations with condylar surfaces that
present bone proliferation. ENA-78, CXCL14 and MMP-9 levels
were correlated to morphological differences in the posterior
surface of the condyle. Only ENA-78 continued to reveal signiﬁ-
cant correlations when the ﬁndings were corrected for false
discovery rate of 0.2 (Fig. 5).of OA vs control morphological differences. Note that even at their initial diagnostic
roup with long history of OA. In the DiProPerm graphic results, the left panel shows the
oups can be separated. The horizontal axis is the projected value, and the vertical axis
for the full data set, with each color show the sub-histograms for that group. The right
t-statistic are shown as black dots. The thick black curve is a smooth histogram of the
the tails of these distributions with respect to the green line (the actual t statistic) both
Fig. 4. Quantitative assessment of condylar morphology. The top row shows comparisons using vector distance maps and signed distance maps computed locally at each corre-
spondent surface point. Note that the vectors point inward in the areas indicative of bone resorption and outward in the areas of bone overgrowth. The bottom row shows the
Statistical signiﬁcance maps for comparison of group morphology. The average OA models were statistically signiﬁcant different from the controls in the superior articular surface of
the condyles at initial diagnosis of OA. Bone changes are signiﬁcantly progressive in the condyle except on the superior surface of the lateral pole that resorbs early in the disease
progression.
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GDF15 levels were signiﬁcantly correlated with morphological
differences in the anterior surface of the condyle. CXCL14 levels
were correlated to morphological differences in the posterior sur-
face of the condyle. 6ckine, ENA-78, TIMP-1, CXCL16, MMP-3, PAI-1,
VE-Cadherin, VEGF, MIP-1b, EGF, GM-CSF, TGFb1, TNFa, IFNg, IL-1a,
IL-6 and BDNF levels were signiﬁcantly correlated tomorphological
variability in the latero-superior surface of the condyle. ENA-78,
MMP-3, PAI-1, VE-Cadherin, VEGF, GM-CSF, TGF1, IFNg, IL-1a and
IL-6 levels still presented signiﬁcant correlations when the ﬁndings
were corrected for false discovery rate of 0.2 (Fig. 5).
In the control subjects for both synovial ﬂuid and serum sam-
ples, the protein levels presented small interactions with condylar
morphology that were not present with false discovery rate
correction except for ANG in serum. ANG serum levels were
signiﬁcantly correlated with the superior surface of the condyle (P-
value < 0.05) and even when corrected for false discovery of 0.2
(Figs. 5 and 6).
Discussion
This study is the ﬁrst to report an association between speciﬁc
OA biomarkers and morphological variability at speciﬁc anatomic
regions in 3D TMJ condyle surface. Advances in proteomics and 3D
shape analysis have brought expectations for application of
increased knowledge about mechanisms of OA toward more
effective and enduring therapies. This study highlights metrics and
methods that may prove instrumental in charting the landscape of
evaluating individual molecular and imaging markers so as to
improve diagnosis, prognosis, and mechanism-based therapy.Conditions such as OA, rheumatoid arthritis, juvenile idiopathic
arthritis, psoriatic arthritis, gout, ankylosis, spondylitis, and idio-
pathic condylar resorption require a comprehensive diagnostic
model that integrates clinical, morphological and biomolecular
assessments. Establishing connections between speciﬁc biomarker
data and 3D imaging will possibly result in treatment modalities
more speciﬁcally targeted towards the prevention or even reversal
of joint destruction. Recently, the use of novel 3D imaging tech-
niques using CBCT in conjunction with SPHARM-PDM shape anal-
ysis has been validated for use in identifying and measuring
simulated discrete, bony defects in condyles as well as being used
to identify various forms of osteoarthritic condylar changes such as
ﬂattening erosions and osteophyte formation and establishing a
possible continuum of pathologic change in TMJ OA19,34. Radio-
graphic signs of bony changes associated with TMJ arthritides
include irregular and possibly thickened cortical outlines (scle-
rosis), erosions, osteophyte formation, subchondral cysts, and
ﬂattening and narrowing of the joint space35. CBCT images allow
reliable detection and localization of bony changes, and increase
the possibility for early detection of TMJ degenerative processes in
asymptomatic patients36. Early diagnosis and treatment of
destructive inﬂammatory conditions is important to further control
bone destruction successfully.37
This study demonstrated statistically signiﬁcant smaller con-
dyles in the OA group as compared to the control average and that
signiﬁcant bone loss in the superior and lateral articular surfaces
has already occurred at initial diagnosis of OA. The overlays and
signed distances between average OA and control condylar models,
revealed that bone apposition/reparative proliferation in the
antero-superior surface of the OA condyle were characteristic of OA
Table II
Median levels in pg/ml for serum and synovial ﬂuid. Levels below the limit of detection are shown with red borders and variations of approximately 2 or greater between
groups are highlighted
Biomarker
Serum Data Synovial Fluid Data
Limit of 
Detection
Highest 
StandardsControl 
Median
Control Range
OA    
Median
OA    Range
Control 
Median
Control Range
OA    
Median
OA    Range
ANG 2,070.90 1524.5-2445.9 1,952.20 1613.7- 2,154.7 350.5 21.2-1665.8 884.5 7.8- 2,154.7 1.22 3,000.00
BDNF 6,616.40 443.8-20955.6 4,761.50 313.2- 13,809.8 0.9 0.0-109.9 4.5 0.0-222.9 11.03 15,000.00
BMP-2 5,331.30 1085.9-218863.1 5,304.20 2256.7- 9751.4 2,085.20 1345.7-2573.2 2,398.90 1245.9-4,696.4 1,182.83 60,000.00
CXCL14/BRAK 822.6 0.0-3122.1 1,564.50 341.7-2632.4 1,298.10 195.8-2191.0 902 439.3- 2,950.5 682.39 150,000.00
MIP-1b 349.2 176.4-635.1 290.6 155.0-639.1 4.3 1.1-9.4 5 1.5-9.4 3.31 1,500.00
MMP-10 1.2 0.0-31.1 1.4 0.0-2.3 90.4 0.0-466.0 85.4 0.4-1385.5 1.72 3,000.00
MMP-2 5,708.10 924.6-848645.5 6,233.00 286.8- 16873.3 843.9 0.0-5256.9 402.4 0.0-11292.5 311.68 150,000.00
MMP-3 13,843.60 4846.7-22500.7 13,980.10 8960.1-26941.1 19,266.60 0.0-222804.2 9,949.60 47.5-55555.9 120.83 45,000.00
MMP-7 1,221.00 0.0-91135.6 1,316.60 0.0-12370.3 2,930.60 0.0-9832.6 1,452.00 0.0-6152.4 974.1 1,200,000.00
MMP-9 22,069.70 9955.6-32307.8 14,406.00 6962.9-22894.4 386.7 9-7626.0 272.4 6.3-14103.9 11.82 15,000.00
PAI-I 32,243.50 1981.8-43397.9 29,660.30 12808.7-42409.0 999.5 140.2-4108.8 818.3 247.6- 2715.3 198 60,000.00
RANK 760.4 267.7-191031.1 734.6 0.0-2278.6 241.5 6.9-1186.9 242.1 0.0-759.8 242.18 150,000.00
TIMP-1 136,076.60 76383.8-170120.4 110,599.80 95557.8-152587.6 13,998.10 180.6-41469.2 21,937.50 45.8-44188.5 48.99 60,000.00
VE-Cadherin 31,692.80 1074.9-46799.0 29,712.60 3544.7- 66899.9 2,342.60 0.0-4666.0 2,120.30 0.0-5365.9 2,190.16 300,000.00
6ckine 6,056.60 1262.8-25302.9 4,224.00 533.9-10835.2 1,241.20 0.0-2747.9 705.4 0.0-3778.6 888.52 60,000.00
BLC 28.6 3.2-216.8 36.9 12.4-785.6 1.2 0.0-6.9 1 0.0-6.4 8.04 15,000.00
CXCL16 4,245.20 3611.6-9533.3 4,392.20 3465.1-6291.8 18.2 0.0-518.9 160.6 2.1-499.9 11.52 15,000.00
EGF 776.7 107.7-1607.4 525.2 152.8- 1422.3 2 0.0-3.7 1.8 0.0-26.7 1.33 600
ENA-78 8,010.20 649.4-20678.2 6,807.10 1062.1-19987.2 12.3 0.0-61.8 26.5 0.0-156.7 23.59 15,000.00
GDF-15 1,013.60 415.2-1690.9 926.3 535.4-3320.1 2.6 0.1-16.5 6.1 0.6-35.5 1.8 3,000.00
GM-CSF 16.3 7.8-66.1 16 4.9-43.1 1.2 0.0-4.8 1.8 0.0-12.6 4.1 1,500.00
IFNγ 49.7 7.0-148.5 39.2 9.5-105.1 8.2 0.0-16.2 8 0.0-40.2 30.76 15,000.00
IL-1α 9.3 1.9-44.5 9.6 0.0-19.6 2.4 0.0-11.3 1.9 0.0-5.6 6.29 3,000.00
IL-6 40.8 16.5-129.4 42.4 15.3-68.6 5.4 0.0-13.9 5.8 0.0-25.2 10.42 3,000.00
MCP-1 134.3 54.1-261.1 106.9 48.5-476.8 8 0.6-34.5 7 0.7-23.8 7 3,000.00
MIP-1a 26.8 0.0-134.9 21.2 0.0-60.4 8.5 0.0-21.2 9.2 0.0-18.0 16.27 15,000.00
OPG 1,010.50 665.5-1725.7 1,021.70 500.8-1241.0 353.8 0.1-9582.6 328.9 0.0-9899.1 31.8 30,000.00
TGFβ1 7,383.70 226.1-34460.3 7,147.00 0.0-33961.1 949.9 0.0-3415.8 898.6 0.0-3816.4 1,240.87 150,000.00
TIMP-2 8,582.90 6377.2-13778.5 9,129.90 6071.8-12209.9 547.2 4.2-8516.6 2,236.20 4.6-4597.9 10.65 15,000.00
TNFα 307.6 67.1-936.9 286.8 13.1-549.4 35 0.0-125.6 39.3 .0-181.1 53.95 3,000.00
VEGF 105.6 17.4-367.0 76.2 23.3-227.9 17.6 4.7-43.6 20.8 6.7-68.4 5.31 3,000.00
ICAM-1 22,786.40 16174.9-61849.4 18,286.20 11771.4- 54910.3 747.6 0.0-1270.4 814.5 104.9-1888.8 165.84 150,000.00
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patients.
In the synovial ﬂuid samples, two of the most striking results of
the MANCOVA analysis show that the levels of MMP-3 in synovial
ﬂuid, that were ~2 fold lower in the OA group compared to the
controls, were correlated to areas of bone apposition/reparative
proliferation that occurs in the anterior surface of the condyles, and
ENA-78 was strongly correlated (P < 0.01) to changes in the lateral
pole and the posterior surface of the medial pole in the TMJ OA
group (Fig. 5).
As a member of the chemokine family, CXCL14/BRAK induces
chemotaxis of monocytes, however it has been suggested that it is
involved more in the homeostasis of monocyte-derived macro-
phages, which are associated with pathologic changes in OA38. It isinteresting to note that in this study local and systemic levels of
CXCL14/BRAK shows the same pattern of morphologic correlations
(Figs. 5 and 6).
The biomarkers for which no association with morphology was
established serve various physiologic and pathophysiologic pro-
cesses and have been implicated in other studies as playing a role in
arthritis13. For example, MMP-2, which demonstrated differences
in detection level between the OA and control groups in the sy-
novial ﬂuid, is involved in the degradation of type IV collagen, the
major structural component of basement membranes and plays a
role in the inﬂammatory response38. Neither of these processes
necessarily correlate to bony changes in OA, but might be more
involved in the pathology of associated tissues (i.e., the lining of the
synovial membrane).
Fig. 5. Results of Shape Analysis MANCOVA for Proteins in the synovial ﬂuid and serum that presented statistically signiﬁcant Pearson correlations between biomarker levels and
morphology.
L.H.S. Cevidanes et al. / Osteoarthritis and Cartilage 22 (2014) 1657e16671664Also, TIMP-2, which again was elevated in the synovial ﬂuid
samples for the OA group, is an inhibitor of MMPs, and is thought to
be critical in maintaining tissue homeostasis through interactions
with angiogenic factors and by inhibiting protein breakdown pro-
cesses, an activity associated with tissues undergoing remodeling
of the ECM.
Interestingly, protein level measurements were much higher in
serum than in synovial ﬂuid. It could be questioned that arthritis
localized in such small joints such as the TMJs may not lead to
changes in systemic levels of proteins and that possibly undiag-
nosed arthritis of other joints in the body maybe confounders in
serum protein expression. In this study, the level of 17 proteins in
serum were signiﬁcantly correlated with the resorption in the
antero-superior surfaces of condylar lateral pole as shown in Fig. 5:
6ckine, ENA-78, TIMP-1, CXCL16, MMP-3, PAI-1, VE-Cadherin, VEGF,
MIP-1b, EGF, GM-CSF, TGFb1, IFNg, TNFa, IL-1a, IL-6 and BDNF.
Because this study ﬁndings represent high dimensional low samplesize data, after correction of ﬁndings using a false discovery rate of
0.2, ENA78, MMP3, PAI-1, VE-Cadherin, VEGF, GM-CSF, TGFb1, IFNg,
IL-1a and IL-6 levels still presented signiﬁcant correlations which
indicates that 20% of the signiﬁcant locations of interactions are
expected to be falsely signiﬁcant, but the overall pattern represents
the interactions between those protein levels/morphological vari-
ability (Fig. 5).
In the control subjects both in synovial ﬂuid and serum, protein
levels presented small interactions with condylar morphology in
condylar surface regions that differ from the OA group. However,
those small interactions cannot be veriﬁed when use false discov-
ery rate correction. ANG levels were signiﬁcantly correlated with
the superior surface of the condyle (P-value < 0.05) and evenwhen
corrected for false discovery of 0.2 (Fig. 5).
The biological investigation limited inclusion in the OA group to
those individuals with a recent diagnosis and onset. Several of the
biomarkers investigated did not demonstrate signiﬁcantly variable
Fig. 6. Summary of biology/morphology interactions.
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morphological association could be established, have been previ-
ously investigated by other groups and found to be associated with
clinical diagnosis of OA, either in the TMJ or another joint. It is
possible that by limiting this investigation to recent onset OA, the
disease had not progressed to a stage where these biomarkers play
as paramount of a role.
A limitation of this study was the inability to test biomarkers in
pairs or groups to evaluate whether or not there is cross-reactivity
between them that is associated with condylar morphology. This
should be an aim of future investigations in this area, as testing
biomarkers in groups will likely be a more accurate representation
of the in vivo state.39
Without FDR correction, 22 cytokines presented interactions
with early signs of bone remodeling in the articular surfaces of
the condyles that are already observed at the ﬁrst clinical diag-
nosis. The levels of MMP-3 in synovial ﬂuid, that were ~2 fold
lower in the OA group compared to the controls, were correlated
to the bone apposition that occurs in the anterior surface of the
condyles and leads to characteristic changes in condylar torque
and morphology. Other proteins in serum and synovial ﬂuid that
may play a role in the bone apposition of the anterior surface of
the condyles include ANG, GDF15, TIMP-1, CXCL16 and MMP-7.
Bone resorption with ﬂattening and reshaping of the lateral
pole of the condyle involves molecular pathways with interaction
of 17 proteins measured in this study: 6ckine, ENA-78, TIMP-1,
CXCL16, MMP-3, PAI-1, VE-Cadherin, VEGF, MIP-1b, EGF, GM-CSF,
TGFb1, IFNg, TNFa, IL-1a, IL-6 and BDNF. Considering the use of
FDR correction for more conservative conclusions in this pioneer
study, levels of 10 proteins in serum samples and 1 protein in
synovial ﬂuid were correlated with resorptive bone remodeling
in OA subjects Six other protein levels in synovial ﬂuid were
correlated with bone overgrowth in the anterior articular surface.
Such interactions are a ﬁrst step to elucidate contributions of
various biomarkers to characteristic phenotypes of an early onsetTMJ OA, while advancing towards developing a comprehensive
OA model.
These study ﬁndings revealed a comprehensive inﬂammatory,
angiogenic, and tissue destruction biomarker proﬁle that correlates
with the bone resorption and repair at the articular surfaces of the
condyle. The novel aspect of this study is that, even tough the
ability of the biomarkers to predict progression was not address-
able in the cross-sectional study design, these biomarkers can be
reasonable surrogate biomarkers of tissue destruction and/or repair
overtime, as well as classiﬁcation schemes. The synovial and
serum-derived biomarkers may be predictive of real-time changes
or predictive of future resorption. Future studies may now allow
combinatorial biomarker assessments such as receiver operating
characteristic (ROC) curves on disease vs health.Declaration of each author's contributions
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